Some links in this article are partner links. If you sign up through one, we may earn a commission at no cost to you. It never changes which panels we recommend or what we say about them.
5 Reasons You Keep Getting Rejected From Clinical Trials (and How to Qualify)
You applied to three studies. You answered every question honestly. And three times you got the same email: "Unfortunately, you don't qualify for this study."
Frustrating — but completely normal. Most applicants do not qualify for any given trial, and a high screen-fail rate is built into how research works. Rejection almost never means something is wrong with you. It means you didn't match one very specific protocol.
Two honest notes before we go further, because they matter more than anything else in this article. First, clinical trials involve real medical risk — you may receive an investigational drug or procedure that is still being studied. Second, the compensation you hear about is a stipend for your time and travel, not payment for taking a drug. If the money would be your only reason to accept a medical risk, that's a signal to slow down, not sign up. Talk to your own doctor before joining any study.
With that said — if you keep getting screened out, one of these five reasons is almost certainly why.
See which trials you may qualify for →
1. You don't fit the inclusion/exclusion criteria — and that's by design
Every trial runs on a protocol: a document that spells out exactly who can participate. Inclusion criteria describe what the study needs (an age range, a specific diagnosis, a disease stage, no prior treatment with a certain drug class). Exclusion criteria describe what disqualifies you (other conditions, recent surgeries, pregnancy, past participation in a similar study).
These lists are narrow on purpose. A migraine study may need people who get 4 to 14 migraine days per month — not 2, and not 20 — because that's the population the drug is being tested for.
How to work with it: stop treating each rejection as a verdict and start treating applications as a matching problem. The fix is applying to more studies, and to the right ones. Browsing our clinical trials hub will give you a feel for how differently studies are targeted.
2. Your medications and supplements conflict with the study
Current medications are one of the most common disqualifiers, because researchers have to rule out drug interactions. This includes prescriptions, over-the-counter medicines, and even herbal supplements.
Many protocols also require a washout period — a stretch of time (commonly ranging from a few days to several weeks, depending on the drug) where you must be off a particular medication before the study starts.
One safety rule that is not negotiable: never stop a prescribed medication on your own just to qualify for a trial. If a washout is required, it should only happen with your own doctor's knowledge — and in many studies it's managed by the research team under medical supervision. No stipend is worth an unmanaged medication gap.
How to work with it: keep a current, complete medication list (names, doses, how long you've taken them) and disclose all of it, including supplements. Full disclosure gets you matched to studies you actually fit instead of screen-failing late.
3. Your BMI, vitals, or lab work fall outside the window
Healthy-volunteer studies — especially Phase 1 studies — often set physical requirements. BMI windows are common (many protocols land somewhere in roughly the 18–32 range, though it varies by study). Blood pressure, heart rate, ECG results, and standard blood panels can also screen you out, even if you feel perfectly healthy.
This can sting, but it isn't a health diagnosis. It's a protocol requirement, set so researchers can measure the drug's effects in a consistent population.
How to work with it: you can't argue with a lab result, but knowing your numbers helps you target studies you plausibly fit instead of burning time on ones you don't. A side note many people don't realize: screening visits typically include vitals and lab work at no cost to you, so even a screen-fail often leaves you knowing more about your own health than you did before.
4. Smoking, nicotine, alcohol, or recreational drug use
Many healthy-volunteer trials exclude nicotine users entirely — and they don't take your word for it. Cotinine tests can detect nicotine use, including vaping. Protocols also commonly set alcohol limits before and during a study, and most sites run a drug screen at check-in. That screen usually includes marijuana, even in states where it's legal.
How to work with it: report your actual habits. If you use nicotine, don't waste applications on studies that exclude it — filter for ones that accept smokers. They exist; some studies specifically recruit smokers because that's the population being researched. Honest answers up front get you routed to studies where your habits are not a problem.
5. Inconsistent — or dishonest — screener answers
Research coordinators compare everything: your online screener against your phone screen, your phone screen against your in-person visit, your answers against your labs and medical records. Inconsistencies, even innocent ones, read as unreliability and get applications quietly dropped.
And here's the hard rule this entire article rests on: never lie on a screener. Not about a medication, not about your smoking history, not shaving a few pounds off to squeak under a BMI cutoff. Two reasons, and both matter:
- Your safety. Exclusion criteria exist to protect participants from dangerous interactions and complications. Lying your way past one can put you in genuine medical danger.
- Everyone else's safety. Trial data guides real treatment decisions for future patients. Dishonest participants corrupt that data.
There's a practical cost too: research sites keep records, and being caught misrepresenting yourself can end your eligibility across an entire site network. Honesty is both the ethical rule and the winning long-term strategy.
How to work with it: prepare before every screening call. Have your medication list, conditions with rough diagnosis dates, and surgical history written down — and give the same accurate answers every time.
How to actually improve your odds
None of the fixes above involve gaming the system. They involve running a better process:
- Apply to more studies. Screen-failing is the norm, so treat it as a numbers game and keep several applications active at once.
- Target the right category. If you're healthy, look at healthy-volunteer studies. If you have a diagnosis, that condition is often your qualification, not your barrier — condition-specific trials need exactly you.
- Build a "screener kit." Medication list with doses, conditions and dates, surgeries, and an honest summary of smoking and alcohol habits. Same answers, every time.
- Respond fast. Enrollment windows close and slots fill. A study you qualified for last month may be done recruiting today.
- Use matching instead of blind applying. A matching service compares your profile against many protocols at once, which is exactly the inclusion/exclusion problem from reason #1, solved in bulk.
Know your protections before you ever say yes
Qualifying is only step one — and you should walk in knowing your rights. Before any study procedures begin, you'll receive an informed consent document: a plain-language explanation of the study's purpose, procedures, risks, and compensation. Read all of it. Take it home. Ask questions. Discuss it with your own doctor — that's not a formality, it's the point.
You also have the right to withdraw at any time, for any reason, without penalty. Compensation is structured as a stipend for time and travel and is typically prorated if you leave partway through — the consent document will spell out how.
Payouts vary enormously. A simple outpatient visit commonly compensates roughly $50–$150, while multi-week Phase 1 inpatient studies can total several thousand dollars — but nothing is guaranteed, and no stipend should override your comfort with a study's risks. We surface the opportunities; you and your doctor make the medical decision.
Related reading
- How to get paid for clinical trials in 2026
- How much do clinical trials actually pay?
- Healthy volunteer clinical trials: what to expect
The bottom line
Getting rejected from clinical trials doesn't mean you're unqualified as a person — it means you haven't matched the right protocol yet. Fix the process: disclose everything, answer consistently, target the right categories, and apply widely.
See which trials you may qualify for →
Prefer to look around first? Browse open paid studies in our directory to see the kinds of trials recruiting right now.